Cuomo Ornella, Pignataro Giuseppe, Sirabella Rossana, Molinaro Pasquale, Anzilotti Serenella, Scorziello Antonella, Sisalli Maria Josè, Di Renzo Gianfranco, Annunziato Lucio
From the Division of Pharmacology, Department of Neuroscience, Reproductive and Odontostomatological Sciences, School of Medicine, Federico II University of Naples, Naples, Italy (O.C., G.P., P.M., A.S., M.J.S., G.D.R., L.A.); and SDN IRCCS, Naples, Italy (R.S., S.A.).
Stroke. 2016 Apr;47(4):1085-93. doi: 10.1161/STROKEAHA.115.012514. Epub 2016 Mar 15.
The small ubiquitin-like modifier (SUMO), a ubiquitin-like protein involved in posttranslational protein modifications, is activated by several conditions, such as heat stress, hypoxia, and hibernation and confers neuroprotection. Sumoylation enzymes and substrates are expressed also at the plasma membrane level. Among the numerous plasma membrane proteins controlling ionic homeostasis during cerebral ischemia, 1 of the 3 brain sodium/calcium exchangers (NCX3), exerts a protective role during ischemic preconditioning. In this study, we evaluated whether NCX3 is a target for sumoylation and whether this posttranslational modification participates in ischemic preconditioning-induced neuroprotection. To test these hypotheses, we analyzed (1) SUMO1 conjugation pattern after ischemic preconditioning; (2) the effect of SUMO1 knockdown on the ischemic damage after transient middle cerebral artery occlusion and ischemic preconditioning, (3) the possible interaction between SUMO1 and NCX3 and (4) the molecular determinants of NCX3 sequence responsible for sumoylation.
Focal brain ischemia and ischemic preconditioning were induced in rats by middle cerebral artery occlusion. SUMOylation was evaluated by western blot and immunohistochemistry. SUMO1 and NCX3 interaction was analyzed by site-directed mutagenesis and immunoprecipitation assay.
We found that (1) SUMO1 knockdown worsened ischemic damage and reduced the protective effect of preconditioning; (2) SUMO1 bound to NCX3 at lysine residue 590, and its silencing increased NCX3 degradation; and (3) NCX3 sumoylation participates in SUMO1 protective role during ischemic preconditioning. Thus, our results demonstrate that NCX3 sumoylation confers additional neuroprotection in ischemic preconditioning.
Finally, this study suggests that NCX3 sumoylation might be a new target to enhance ischemic preconditioning-induced neuroprotection.
小泛素样修饰物(SUMO)是一种参与蛋白质翻译后修饰的泛素样蛋白,在多种条件下被激活,如热应激、缺氧和冬眠,并具有神经保护作用。SUMO化酶和底物也在质膜水平表达。在众多控制脑缺血期间离子稳态的质膜蛋白中,三种脑钠/钙交换蛋白(NCX3)之一在缺血预处理期间发挥保护作用。在本研究中,我们评估了NCX3是否是SUMO化的靶点,以及这种翻译后修饰是否参与缺血预处理诱导的神经保护。为了验证这些假设,我们分析了:(1)缺血预处理后的SUMO1缀合模式;(2)SUMO1敲低对短暂大脑中动脉闭塞和缺血预处理后缺血损伤的影响;(3)SUMO1与NCX3之间可能的相互作用;(4)负责SUMO化的NCX3序列的分子决定因素。
通过大脑中动脉闭塞诱导大鼠局灶性脑缺血和缺血预处理。通过蛋白质印迹和免疫组织化学评估SUMO化。通过定点诱变和免疫沉淀试验分析SUMO1与NCX3的相互作用。
我们发现:(1)SUMO1敲低加重了缺血损伤并降低了预处理的保护作用;(2)SUMO1在赖氨酸残基590处与NCX3结合,其沉默增加了NCX3的降解;(3)NCX3的SUMO化参与缺血预处理期间SUMO1的保护作用。因此,我们的结果表明,NCX3的SUMO化在缺血预处理中赋予额外的神经保护作用。
最后,本研究表明,NCX3的SUMO化可能是增强缺血预处理诱导的神经保护作用的新靶点。